For episode 5, we chat with Matt Schwartz, CEO & Co-Founder of Virgo.Listen in to  find out Matt's thoughts on Decentralized Clinical Trials and why they aren't really applied well in the realm of IBD trials.First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO, hosted by Simon Burns, CEO & Co-Founder.Episodes launch weekly on Tuesdays.To view the full episode transcript, click here.Interested in being featured as a guest on First In Human? Please reach out to catie@vial.com.